R.I. Olivier

497 total citations
6 papers, 342 citations indexed

About

R.I. Olivier is a scholar working on Reproductive Medicine, Genetics and Molecular Biology. According to data from OpenAlex, R.I. Olivier has authored 6 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Reproductive Medicine, 4 papers in Genetics and 1 paper in Molecular Biology. Recurrent topics in R.I. Olivier's work include Ovarian cancer diagnosis and treatment (5 papers), BRCA gene mutations in cancer (4 papers) and Cancer-related molecular mechanisms research (1 paper). R.I. Olivier is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), BRCA gene mutations in cancer (4 papers) and Cancer-related molecular mechanisms research (1 paper). R.I. Olivier collaborates with scholars based in Netherlands. R.I. Olivier's co-authors include Marc van Beurden, Senno Verhoef, Matti A. Rookus, Thea M. Mooij, Laura J. van’t Veer, Marc J. van de Vijver, Joanne A. de Hullu, Brenda Hermsen, Hester H. van Boven and Curt W. Burger and has published in prestigious journals such as British Journal of Cancer, European Journal of Cancer and Gynecologic Oncology.

In The Last Decade

R.I. Olivier

5 papers receiving 334 citations

Peers

R.I. Olivier

RM

GENET

PFM

CR

OG

Gila Hornreich Israel

Jack Basil United States

Fiona Lalloo United Kingdom

Marc P.M.L. Snijders Netherlands

Elisabetta Razzaboni Italy

Jarosław Dębniak Poland

P.M.L.H. Vencken Netherlands

C. J. van Asperen Netherlands

J. van Nagell United States

Barnaby Rufford United Kingdom

Gila Hornreich Israel

R.I. Olivier

208 ×0.8

RM

370 ×1.8

GENET

131 ×1.8

PFM

89 ×1.3

CR

56 ×1.0

OG

Citations per year, relative to R.I. Olivier R.I. Olivier (= 1×) peers Gila Hornreich

Countries citing papers authored by R.I. Olivier

Since Specialization

Citations

This map shows the geographic impact of R.I. Olivier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.I. Olivier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.I. Olivier more than expected).

Fields of papers citing papers by R.I. Olivier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.I. Olivier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.I. Olivier. The network helps show where R.I. Olivier may publish in the future.

Co-authorship network of co-authors of R.I. Olivier

This figure shows the co-authorship network connecting the top 25 collaborators of R.I. Olivier. A scholar is included among the top collaborators of R.I. Olivier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.I. Olivier. R.I. Olivier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hermsen, Brenda, R.I. Olivier, René H.M. Verheijen, et al.. (2007). No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. British Journal of Cancer. 96(9). 1335–1342. 104 indexed citations

2.

Olivier, R.I., Marc van Beurden, & Laura van ‘t Veer. (2006). The role of gene expression profiling in the clinical management of ovarian cancer. European Journal of Cancer. 42(17). 2930–2938. 16 indexed citations

3.

Olivier, R.I., et al.. (2005). 00060: CA125 AND TRANSVAGINAL ULTRASOUND MONITORING IN HIGH RISK WOMEN CANNOT PREVENT THE DIAGNOSIS OF ADVANCED OVARIAN CANCER. International Journal of Gynecological Cancer. 15. 68–68.

4.

Olivier, R.I., et al.. (2005). CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecologic Oncology. 100(1). 20–26. 124 indexed citations

5.

Olivier, R.I., Marc van Beurden, Matti A. Rookus, et al.. (2004). Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. British Journal of Cancer. 90(8). 1492–1497. 92 indexed citations

6.

Olivier, R.I., et al.. (2004). Additional salpingectomy after previous prophylactic oophorectomy in high-risk women: sense or nonsense?. Gynecologic Oncology. 96(2). 439–443. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact